House bill seeks to restore $1.18B cut from military medical research

What does this do?

HR 3906 would restore approximately $1.18 billion in funding to the Defense Health Agency's medical research budget that was cut by a 2025 government funding law. The restored money would go to the Congressionally Directed Medical Research Programs, or CDMRP, at the same levels and in the same manner established by a 2024 spending law. The bill does not create new programs but would reinstate funding that was already planned and approved.

Who does it affect?

Military service members, veterans, and their families are most directly affected, since CDMRP research targets conditions such as cancer and traumatic brain injury. Scientists, universities, and medical institutions that receive grants through these programs also stand to be affected, as their funding was at risk of being eliminated.

Why does it matter?

Without this bill, approximately $1.18 billion in previously approved medical research funding would remain cut from the Defense Health Agency's budget. Research programs focused on diseases and health conditions affecting military personnel would lose funding already designated under a 2024 spending law.

What does it cost, and who pays?

• $1.18B to Defense Health Agency
• Funds CDMRP research programs
• Restores prior 2024 approvals